vimarsana.com

Page 14 - சீன கலைக்கழகம் ஆஃப் மருத்துவ அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CAR-T Therapy: Combating Cytokine Release Syndrome

CAR-T Therapy: Combating Cytokine Release Syndrome Sponsored Content by ACROBiosystemsMay 21 2021 CAR-T cell therapy offers the hope of a cure to a number of cancer patients. Yet, in spite of the great effectiveness, more attention has been paid to the toxicity of the therapy known as cytokine release syndrome (CRS). This article is aimed at summarizing the main points of assessment, grading and management of CRS in CAR-T Therapy and provide answers to the following questions: How to identify the onset of CRS clinically? What is CRS management? How to use tocilizumab in CRS management? Assessment, grading and management of CRS in CAR-T therapy

Benefits of Chinese cooperation to be extended to other Muslim countries

‘Benefits of Chinese cooperation to be extended to other Muslim countries’ Islamabad May 24, 2021 Islamabad : Coordinator General, COMSTECH, Dr. Iqbal Muhammad Choudhary vowed to extend the benefits of Chinese cooperation in various sectors in Pakistan to the other Muslim countries through the platform of COMSTECH. “China has been cooperating with Pakistan in different fields of life whether it is virology or vaccine development or biomedical devices. There were so many fields in which COMSTECH can benefit from Chinese expertise and help Muslim countries to develop their capacity in these futuristic endeavours. From the platform of COMSTECH, we would like these benefits of Chinese cooperation spread to the other Muslim countries,” he said in an interview with this agency.

Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118 5% to RMB1 91 Billion

Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion Contribution of Sales of New Products to Revenue Rises to 47.4% Driving Revenue Up by 16.4% HONG KONG, May 24, 2021 - (ACN Newswire) - Sino Biopharmaceutical Limited ( Sino Biopharmaceutical or the Company , together with its subsidiaries, the Group ) (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2021. Development Highlights Chia Tai - Tianqing Pharmaceutical Group Co. Ltd. ( CT Tianqing ), a member company of the Group, and Beijing-based Genetron Holdings Limited (NASDAQ: GTH) signed a strategic cooperation agreement on early screening of liver cancer. The two parties will work together in the next three years in selected areas in the country to serve those at high risk of developing liver cancer, including Hepatitis B carriers a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.